O'Toole David D. 4/A
4/A · Abraxis BioScience, Inc. · Filed Mar 3, 2009
Insider Transaction Report
Form 4/AAmended
O'Toole David D.
CFO & Executive VP
Transactions
- Tax Payment
Common Stock
2009-02-03$70.40/sh−134$9,434→ 1,107 total - Award
Common Stock
2009-02-03+1,241→ 1,241 total
Footnotes (1)
- [F1]On February 3, 2009, the reporting person was granted1, 241 restricted stock units, of which 310 units were vested on the date of grant with the remaining units vesting in 2 equal installments on January 15, 2010 and January 15, 2011.